Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma

Our aim was to correlate patterns of failure with target volume delineations in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity‐modulated radiation therapy (IMRT) and to report subjective xerostomia outcomes after IMRT as compared with conventional radiation therapy (CRT).

[1]  C. Perez,et al.  Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  R. Popple,et al.  A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT. , 2004, International journal of radiation oncology, biology, physics.

[4]  H. Curtin,et al.  An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. , 1999, Archives of otolaryngology--head & neck surgery.

[5]  Sang‐wook Lee,et al.  Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[6]  M. Zelefsky,et al.  Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. , 2006, International journal of radiation oncology, biology, physics.

[7]  J. Dempsey,et al.  Late Xerostomia After Intensity-Modulated Radiation Therapy Versus Conventional Radiotherapy , 2005, American journal of clinical oncology.

[8]  E. Strong,et al.  Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue , 1997, Head & neck.

[9]  D. Wazer,et al.  Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck , 1992, Cancer.

[10]  Daniel A Low,et al.  Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. , 2003, International journal of radiation oncology, biology, physics.

[11]  J. Deasy,et al.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.

[12]  P. Xia,et al.  Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. , 2003, International journal of radiation oncology, biology, physics.

[13]  P. Xia,et al.  Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. , 2001, International journal of radiation oncology, biology, physics.

[14]  J. Torner,et al.  Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. , 1990, International journal of radiation oncology, biology, physics.

[15]  L. Dawson,et al.  Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. , 2003, International journal of radiation oncology, biology, physics.

[16]  M K Martel,et al.  Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.

[17]  Satyandra K. Gupta,et al.  Twice a day versus once a day radiation therapy in head and neck cancer , 1989 .

[18]  Ping Xia,et al.  A population-based atlas and clinical target volume for the head-and-neck lymph nodes. , 2004, International journal of radiation oncology, biology, physics.

[19]  L. Souhami,et al.  Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. , 1991, International journal of radiation oncology, biology, physics.

[20]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  L. Bastholt,et al.  106 Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trial , 1997 .

[22]  P. Fox,et al.  Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. , 1993, International journal of radiation oncology, biology, physics.

[23]  Ping Xia,et al.  Intra-fraction patient motion in head/neck cancer patients undergoing intensity-modulated radiation therapy (IMRT) , 2003 .

[24]  D A Low,et al.  Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience , 2000, International journal of cancer.

[25]  A. Garden,et al.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. , 2000, International journal of radiation oncology, biology, physics.

[26]  G. Field,et al.  Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[27]  J. Buatti,et al.  Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. , 2005, International journal of radiation oncology, biology, physics.

[28]  C. Scully,et al.  Oral health care for the cancer patient. , 1996, European journal of cancer. Part B, Oral oncology.

[29]  Cai Grau,et al.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial , 2003, The Lancet.

[30]  E. B. Butler,et al.  Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[31]  Christopher U. Jones,et al.  Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  C. Tsien,et al.  Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. , 2005, International journal of radiation oncology, biology, physics.

[33]  Joseph O Deasy,et al.  Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. , 2004, International journal of radiation oncology, biology, physics.

[34]  Margie Hunt,et al.  Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. , 2006, International journal of radiation oncology, biology, physics.

[35]  K. Chao,et al.  Patterns of Failure in Patients Receiving Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancer , 2005 .

[36]  Vincent Grégoire,et al.  Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. , 2004, International journal of radiation oncology, biology, physics.

[37]  L. Dawson,et al.  Salivary Gland Sparing and Improved Target Irradiation by Conformal and Intensity Modulated Irradiation of Head and Neck Cancer , 2003, World Journal of Surgery.

[38]  Heikki Joensuu,et al.  Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  E. B. Butler,et al.  Accelerated fractionation for head and neck cancer using the smart (simultaneous modulated accelerated radiation therapy) boost technique , 2001 .

[40]  R Mohan,et al.  Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. , 2000, International journal of radiation oncology, biology, physics.

[41]  J. Horiot,et al.  Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[43]  R K Ten Haken,et al.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.